Literature DB >> 23628511

Pain in CF: review of the literature.

Trudy Havermans1, Kristine Colpaert, Kris De Boeck, Lieven Dupont, Janice Abbott.   

Abstract

BACKGROUND: This review evaluated pain research in cystic fibrosis (CF).
METHODS: OVID MEDLINE, CINAHL, AMED, Web of Science, Pubmed, PsychINFO and PsychARTICLES were searched from January 1995-December 2012 to locate papers assessing pain in CF. A proforma was used to record the rationale for the study, characteristics of the sample, pain assessment tools, pain location, frequency and severity, treatment/self-management, coping and the impact on daily activities and quality of life.
RESULTS: All studies (n=13) were retrospective. Chest and abdominal pains were most commonly reported. Pain was negatively associated with pulmonary exacerbations, quality of life and treatment adherence. Approximately 50% of patients do not consult their GP or CF team about pain, with many patients reporting self-management.
CONCLUSION: A high incidence of pain is reported in CF although there is little standardization of CF pain measurement. The way forward is to develop guidelines on how to assess pain and provide adequate treatment for pain in CF.
Copyright © 2013 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cystic fibrosis; Pain; Pain assessment; Quality of life; Treatment

Mesh:

Year:  2013        PMID: 23628511     DOI: 10.1016/j.jcf.2013.04.001

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  7 in total

1.  Validity and Reliability of a Novel Multimodal Questionnaire for the Assessment of Abdominal Symptoms in People with Cystic Fibrosis (CFAbd-Score).

Authors:  Anke Jaudszus; Elisa Zeman; Tatjana Jans; Elena Pfeifer; Harold Tabori; Christin Arnold; Ruth K Michl; Michael Lorenz; Natalie Beiersdorf; Jochen G Mainz
Journal:  Patient       Date:  2019-08       Impact factor: 3.883

Review 2.  Modulating Innate and Adaptive Immunity by (R)-Roscovitine: Potential Therapeutic Opportunity in Cystic Fibrosis.

Authors:  Laurent Meijer; Deborah J Nelson; Vladimir Riazanski; Aida G Gabdoulkhakova; Geneviève Hery-Arnaud; Rozenn Le Berre; Nadège Loaëc; Nassima Oumata; Hervé Galons; Emmanuel Nowak; Laetitia Gueganton; Guillaume Dorothée; Michaela Prochazkova; Bradford Hall; Ashok B Kulkarni; Robert D Gray; Adriano G Rossi; Véronique Witko-Sarsat; Caroline Norez; Frédéric Becq; Denis Ravel; Dominique Mottier; Gilles Rault
Journal:  J Innate Immun       Date:  2016-03-18       Impact factor: 7.349

Review 3.  Pain and its clinical associations in individuals with cystic fibrosis: A systematic review.

Authors:  Annemarie L Lee; Sarah Rawlings; Katharine A Bennett; David Armstrong
Journal:  Chron Respir Dis       Date:  2016-02-12       Impact factor: 2.444

4.  Impact of osteopathic treatment on pain in adult patients with cystic fibrosis--a pilot randomized controlled study.

Authors:  Dominique Hubert; Lucile Soubeiran; Fabrice Gourmelon; Dominique Grenet; Raphaël Serreau; Elodie Perrodeau; Rafael Zegarra-Parodi; Isabelle Boutron
Journal:  PLoS One       Date:  2014-07-16       Impact factor: 3.240

5.  A Cross-Sectional Study of the Psychological Needs of Adults Living with Cystic Fibrosis.

Authors:  Smita Pakhale; Justine Baron; Michael Armstrong; Georgio Tasca; Ena Gaudet; Shawn Aaron; William Cameron; Louise Balfour
Journal:  PLoS One       Date:  2015-06-23       Impact factor: 3.240

6.  Prevalence and Impact of Rheumatologic Pain in Cystic Fibrosis Adult Patients.

Authors:  Axelle Schmoll; Claire Launois; Jeanne-Marie Perotin; Bruno Ravoninjatovo; Muriel Griffon; Sophie Carré; Pauline Mulette; Julien Ancel; Jean Hagenburg; François Lebargy; Gaëtan Deslée; Jean-Hugues Salmon; Sandra Dury
Journal:  Front Med (Lausanne)       Date:  2022-02-08

7.  Satisfaction and effectiveness of opioid pain management among adults with cystic fibrosis: A mixed methods study.

Authors:  Sarah Allgood; Jessica L Zemlak; Elisabeth Dellon; Siddhartha G Kapnadak; Jessica Goggin; Noah Lechtzin
Journal:  J Cyst Fibros       Date:  2021-07-10       Impact factor: 5.482

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.